Dapagliflozin Devatis 10 mg, Filmtabletten - 28 Swissmedic Key 69746003 Registration Holder Devatis AG Name Dapagliflozin Devatis 10 mg, Filmtabletten Date of registration 16.01.2025 Introduction of Sequence 16.01.2025 ATC-Classification Dapagliflozin (A10BK01) Revision date WHO WHO-DDD Valid until 15.01.2030 Index Therapeuticus (BSV) Show package size 28 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680697460030 Medication Code Synthetika Pharmacode Disponibility
Composition dapagliflozinum 10 mg, cellulosum microcristallinum, lactosum 53.05 mg, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 1.05 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dapagliflozinum 10 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Lactosum 53.05 mg Macrogol 4000 Natrii Stearylis Fumaras Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :